About: http://data.cimple.eu/claim-review/1b021781474ab3767378e6d6c0e5e1b349c784bf1b342598f69df08b     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:ClaimReview, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
http://data.cimple...lizedReviewRating
schema:url
schema:text
  • A video on Youtube and a post on Facebook have claimed that four volunteers taking part in the Pfizer-BioNTech Covid-19 vaccine trials were left with Bell’s palsy after participating. Bell’s palsy is a weakness or paralysis of one side of the face which is usually temporary, and treated with steroids. The exact cause isn’t known but it’s thought to have something to do with the herpes virus. It’s true that four people who received the vaccine during trials later got Bell’s palsy, but that doesn’t mean the vaccine caused it. The trials in which this occured included 38,000 participants. Although all four people who got Bell’s palsy were in the group who got the vaccine (rather than a placebo), this is not more than we would expect to develop Bell’s palsy in a group of this size by chance. According to the US Federal Drug Administration (FDA), these cases occurred at 3, 9, 37, and 48 days after vaccination. Because these trials were so large, a number of people would be expected to get ill over the period covered by the trial. These illnesses won’t necessarily have been caused by the vaccine, but these kinds of incidents are closely monitored in case they are linked to the vaccine. But in this case, there is no evidence that the vaccine is in any way linked to Bell’s palsy, because if you monitored a group of people this size and they hadn’t had the vaccine, this is about how many people you might expect would develop Bell’s palsy. The FDA’s document on the vaccine explained it this way: “The observed frequency of reported Bell’s palsy in the vaccine group is consistent with the expected background rate in the general population, and there is no clear basis upon which to conclude a causal relationship at this time, but FDA will recommend surveillance for cases of Bell’s palsy with deployment of the vaccine into larger populations.” This doesn’t mean scientists monitoring trials won’t keep observing these sorts of things. And as with all vaccines in the UK, the vaccine’s safety will be continually monitored as it is rolled out to the public, via the yellow card scheme (where information about potential side effects and adverse reactions are monitored and evaluated).
schema:mentions
schema:reviewRating
schema:author
schema:datePublished
schema:inLanguage
  • English
schema:itemReviewed
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software